Skip to content

Drug interactions

Idecabtagene vicleucel + Mercaptopurine

Severity: Major

Idecabtagene vicleucel and Mercaptopurine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mercaptopurine is a cytotoxic immunosuppressant and may impair the function of CAR-T cells. It also adds to the infection risk that follows CAR-T therapy.

What this interaction means in plain words

Idecabtagene vicleucel and Mercaptopurine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Idecabtagene vicleucel belongs to Oncology; Mercaptopurine belongs to Oncology.

Evidence level: Low

Why it happens

Additive immunosuppression and antimetabolite effects on lymphocytes may reduce CAR-T expansion and persistence.

What to do

Avoid mercaptopurine around leukapheresis and CAR-T infusion unless essential, and follow the product labeling and specialist guidance. Monitor closely for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idecabtagene vicleucel and Mercaptopurine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idecabtagene vicleucel with Mercaptopurine?

MediHelp rates the interaction as major. Idecabtagene vicleucel and Mercaptopurine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mercaptopurine is a cytotoxic immunosuppressant and may impair the function of CAR-T cells. It also adds to the infection risk that follows CAR-T therapy.

How serious is the interaction between Idecabtagene vicleucel and Mercaptopurine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid mercaptopurine around leukapheresis and CAR-T infusion unless essential, and follow the product labeling and specialist guidance. Monitor closely for infection.

What other medicines interact with Mercaptopurine?

MediHelp also lists interactions of Mercaptopurine with, for example, Adenovirus types 4 and 7 live, Azathioprine, Bcg vaccine live. The full list is on the Mercaptopurine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in